A rare case report describes an immunocompetent adult whose progressive muscle weakness and elevated CPK turned out to be a...
Final Phase 3 IMpower030 results show that perioperative atezolizumab plus chemotherapy extended median event-free survival to 62.8 months versus 34.9...
A large U.S. real-world study found that ESR1 mutations emerging during first-line therapy for ER-positive metastatic breast cancer are linked...
A new review in the Journal of Cancer Research and Clinical Oncology examines how the NINJ1 protein executes plasma membrane...
A new perspective argues that radiation must be redesigned as an immunological platform to finally unlock the potential of combined...
Marking the 25th anniversary of Nature Reviews Cancer, six leading researchers assess the transformative advances and unfulfilled expectations of a...
A critical review of eight studies from the 2026 ASCO Annual Meeting shows TCR-engineered T-cell therapy produced no treatment-related deaths...
Paired structural snapshots of GPR84 in different conformational states, combined with immune cell assays, reveal how ligands activate, block or...
Researchers are using PD-L1-targeted PET/CT imaging to directly visualise whether the immunotherapy drug atezolizumab saturates its target in tumours, offering...
An international modified Delphi consensus of over 200 haematologists has produced strong agreement on how to safely deliver CPX-351 liposomal...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine